The OU Health Board of Directors on Feb. 4 announced Richard Lofgren, MD, MPH, FACP, as CEO of OU Health, Oklahoma’s only integrated, comprehensive academic health system.
Drug developed to suppress cancerous tumors also has ability to lower blood sugar levels that were elevated due to obesity and Type 2 diabetes.
Researcher at Harold Hamm Diabetes Center receives $1.6 million NIH grant to better understand how non-alcoholic fatty liver disease (NASH).
OU Health to receive more than $1 million to participate in a National Institutes of Health (NIH) initiative to better understand long-term effects of COVID-19 infection.
Jason Sanders, M.D., MBA, senior vice president and provost of the University of Oklahoma Health Sciences Center, has accepted a position at University of Vermont Health.
Min Li, Ph.D., George Lynn Cross Research Professor of Medicine, has been designated president-elect of the American Pancreatic Association.
Dr. Michael Businelle awarded $2.7 million grant from the NIH to test novel smartphone application to reduce anxiety and depression and monitor COVID-19 symptoms.
OU Health and Mercy in Oklahoma City have launched Mercy Clinic - Neurosurgery, a collaboration that provides patients with advanced medical and surgical treatments for disorders of the brain and spine.
A research study published today in the prestigious New England Journal of Medicine shows promise for a new oral medication that is effective for preventing clots without increasing bleeding.
The vision research program at the University of Oklahoma Health Sciences Center and Dean McGee Eye Institute recently received a five-year, $2.9 million grant renewal from the National Eye Institute.
A ribbon-cutting ceremony and open house marked the official opening of the new OU Health Center for Pregnancy and Newborn Health (CPNH).